Marc A. Cohen

Co-Founder at C4 Therapeutics, Inc.

Marc A. Cohen

Marc A. Cohen

Co-Founder at C4 Therapeutics, Inc.

Overview
Career Highlights

PharmAthene, Inc.
Air Cargo, Inc.
OTG Software, Inc.

RelSci Relationships

885

Number of Boards

7

Birthday

1963

Age

57

Contact Data
Trying to get in touch with Marc A. Cohen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Marc A. Cohen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at C4 Therapeutics, Inc.

Relationship likelihood: Strong

Scientific Founder at C4 Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Cobro Ventures, Inc.

Relationship likelihood: Strong

Advisory Partner at NewSpring Capital

Relationship likelihood: Strong

Former President at Lenel Systems International, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Acetylon Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at EG Capital Group LLC

Relationship likelihood: Strong

Scientific Founder at OncoPep, Inc.

Relationship likelihood: Strong

Pediatric Hematology/Oncology at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Director at OncoPep, Inc.

Relationship likelihood: Strong

Paths to Marc A. Cohen
Potential Connections via
Relationship Science
You
Marc A. Cohen
Co-Founder at C4 Therapeutics, Inc.
Family Members
Education
M.S. in Electrical Engineering

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

B.S. in Engineering

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Co-Founder
2015 - Current

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in 2015 and is headquartered in Cambridge, MA.

Co-Founder
2013 - Current
Co-Founder
2010 - Current

OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company's product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.

Boards & Committees
Executive Chairman
2015 - Current

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in 2015 and is headquartered in Cambridge, MA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$250K - $500K
2013

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

$500K +
2012

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

$5,000 +
2011

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Transactions
Details Hidden

C4 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Riverbed Technology Inc. purchases OPNET Technologies, Inc.

Details Hidden

Acetylon Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in 2015 and is headquartered in Cambridge, MA.

Details Hidden

OPNET Technologies, Inc. provided application and network performance management solutions. The company's engaged in software products address applications performance management, network planning, engineering and operations, and network research and development. OPNET's solutions deliver broad visibility and monitoring across infrastructure domains as well as deep data collection and analytics to enable powerful root cause diagnosis. The company markets software products and related services in North America primarily through a direct sales force and, to a lesser extent, through a sales program to extend its market reach called the Synergy Program. The company sells products to corporate enterprises, government and defense agencies, network service providers, and network equipment manufacturers. OPNET Technologies was founded by Marc A. Cohen and Alain J. Cohen in 1986 and was headquartered in Bethesda, MD.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marc A. Cohen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marc A. Cohen's profile does not indicate a business or promotional relationship of any kind between RelSci and Marc A. Cohen.